Taufone drops eye

Country: Armenia

Language: English

Source: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Active ingredient:

taurine

Available from:

Liqvor CJSC

ATC code:

S01XA

INN (International Name):

taurine

Dosage:

40mg/ml

Pharmaceutical form:

drops eye

Units in package:

10ml plastic vial-dropper

Prescription type:

Prescription

Authorization status:

Registered

Authorization date:

2016-02-04

Patient Information leaflet

'
>
AO3T
M3 PA
Inpexrop
A.
Ton.rfiH
'
,
:
vrBEPry(AEHO
llpeg oeAarenb
O ap
rur
arororuqecKoro
Coseta
M3.'FA
, ' ( ( , ' ,
) )
3.,Aupo.f,H
:
20L6
r.
HHCTPITKIIVTfl
'
'
'
rro M eALrrIr,rHcKoMy
rrplrMeHeHHro
IIp
en ap aT
a
T A Y ( D O H T M
:
:
:
,::,,'
., .,KaIIJIH,,FJIaAHbIe,
'
.
:
.
:
Perncrpar{Honrmrfi
HoMep
:
Topronoe
Ha3BaHHe:
TaydlourNl
MexnYHapoAHoeHenaTeHToBaHHoeHagnarrue-TaypHH
JlenapcrBeHr{aa
Soprua:
KanJrH
rJra3H:re
4
o/o.
Cocras:
aKTHBHoe:
eeuecreo:
TaypHH
*
40,0
ur;
BcnoMofarenbHue
seuecrBa:
6eHsanxoHnr
xJropHA
-
0,05 Mr, BoA
a
ilnflHrrbeKr,I
uit
-Ao
I n,ln.
O
uucaune
: flpo3parrua.fi
6ecuserHar
xnAKocrb.
aneBTl{qecmatI
rpyilra
-
llpenaparbr
Arr
req
elwrnaroJrornu
rJra3.
Q)apruanorel)
Koa
ATC.
SO1XA
.
'
.
'
'
Oa
pru
arcoJr
o
rurrecKoe
Aeft
crnue
:
taypun
rrBJrrercr
oepoco{epxrauefi
penapaTHBHbre
H
pereHepar{HoHHbre
ts
trt:fri:*-,'|
"'aMrrHolrircnopfi.
.,
Qierpryrupyer
ii:;.,,:.""".-"."
"..r4.A/
/6
,'
"
rpoueccrr
'
''
"'Rpu
sa6oree
an:lrfix
AlacrpotpplllecKoro
xapaKTepa
rr
:a6oresaHnrrx,
conpoBolr(Aaroulkrxcfl
pe3rc,rM
HapyueHueM
ueradoJru3Ma
rura3Hbrx
rxanefi
.
f{penapar
cnoco6crByer
HopManvrcarJr4vr
$yHxunfi
Kreror{Hbrx
Itleu6pau,
aKTHBatIHu
3l-Ieprerr{qecKr{x
vt
o6naeHusrx
npoueccoB,
coxpaHeHu}o
3A
CI{CT
HAI(ONT
EHVTfl
HOHOB
KAJIHfl
H
SneKTponl,rTHoro
cocTaBa r{HTo[na3MbI
I(anblll,t.fi
H
yny
q
ueHI,Ilo
ycJro
Br,rft
upo neAeHHfl
Hep
BHoro
r{Mnv
Jrbca.
()apnatcoKuHemuKfl
I lpu
ruecrHoM
[pr,rh,{eH
eHvrr4
cHcreMHax
a6cop
6rlws
Htr3r(afl.
ffoKasanr{fl
r{ npnMeHeHrr[o
TaycpoH
rpnMeHflror
y
B3pocnbrx
B KaqecrBe
crprMyJr;rropa
penapar?rBubrx
w
pefeHeparopHbrx
llpoueccoB
ilpn
4ucrpo$
krxx
pofoBprubr,
craprrecKHx
Aua6ernyecKux,
TpaBMarHr{ecKHX
u
ffyrleBbrx
KarapaKTax,
nepBgrlnofi
ort(pblToyronrHoia
rrlayroMe
B
coqerar{Hr{
c
B-agpeHo6loraropaMr4
(nns
ylyqueHl4fl
orroKa
BoAflHHcrofi
erarn),
a raroxe
Kar(
cpeAcrBo
crr,rMyJr
trrp4r
BOCCTaHOBprTeJrbHbrx
rrpoqeccoB
npH
TpaBMax
pofoBHrlbr.
Cnoco6 rrpHMeHeHHfl
H
Ao3br
flpu
KarapaKrax
Tay{rout
npl

Summary of Product characteristics

CYMMAPHA.'I
XAPAKTE
PI4
CTI4ITA
JIEKAP
CTB
ETIH
Of
C
IIPEIIAPATA
(sPC)
T A Y Q O H T I \ {
I(ANJIH
TIIA3HbI
C
4OA
1.
KommepqecKoe
HalIMeHoBaHHe
n p e f i a p a r a :
Mexay
HapoAHoe
Ha
HMeHoBa
HHe
a
KTH
BHbrx
2,
ItonHqecrBeunurfi
H
KaqecrBeHHufi
c o c r a B :
TaypHr{
EeHganKoHHrr
xnopuA
Boga
Ans
unrercuufi
3.
(DaprwaueBTnrrecKas
Qopma:
Kanrru
rura3Hbr
e 4a/o
4,
K.nus
HqecKr.re
xa
paKTepHcrHKH
4,1
florcagar{Hff
K TpHMeHeHHK)
TAyo
oH'rM
(TAuroNErNI;
Beulecrn
:
Taypau
(Taurine)
-
40,0
r
-
0,05
r
- l
o l
n
Tay$on
rpnMeHtlor
y
B3pocxblx
B
KaqecrBe
crnMyJrflropa
penapargBHbrx
H
pereneparopHrrx
rrpoueccoB
flpu
.{zcr"po$Eax
poroBzr{br,
crap.recxux
raa6ernuecxux,
TpaBMarr,rqecKltx
I{
nyqeBEIX
KarapaxTax,
nepnu.rnofi
orKpbrroyroJrbnoft
rnayxove
B
coqeragr{u
c
B-aapeHo6no(aropaMr{
(Nn ynyuweutx
orroKa
aoAxnuctoft
nlara),
a raKxe
KaK
cpeAcrBo
o^wrMynflrJvfi
BoccraHoBrnreJr6H6rx
EpoqeccoB
rrpr{
TpaBMaX
poroBuubt.
4.2.
Cnocol
ptlMeneHrq
u
Ao3bl
flp"
KarapaKTax
Tay$on
rpl4Meutltor
B
BHAe
HHcrt{Jr
rrflrJufr
no 1
-Z
rcanilv
2
-
4
paza
B
.{eHb,
e}KeAHeBHo
B
Ter{eHI4e
3
Mec.flUeB.
Itypctr
noBToptlroT
c
MecsrrHbrM
HHcrHrrnHpyroT
,iii
r
i
.
i
.._,,30
MHH
Ao
3aKanbrBaHr-{r
F-a,uperio6noxaropa
(:ruuo.rrora)
r
te,rg4yp
f.ne4enr,'c
noe:nbayrorqrarr,r
nepepblBoM
wa2uegenu.
.
to"'"''"-e{g///
" t
4.3.
rlporuuonoKa3aHufl
/=-
" ' *
flonuueHHa-s
qyBcrBr.rrenbuocrb
K
KoMrroHeHTaM
rrpenapara.
HHTepBaJIoM.
Ilper rpaBMax
H
AHcrpoSHqecKHX
nopaxeHnsx
pofoBgubr
npgMegrror
B
rex
xe
Ao3ax
B Ter{eHHe
Mecf,ua.
llpu
orKpbrroyfqrr6H,gfi,,l{ayKoMe
B
KoHbroHKrHBarrbHbrfi
MerroK
rro 1-2
KanJrn
2
pffi.Filt
ga
Zo
4,3.
Oco6r,re
yKa3aHHfl
flpenapar
coAepx{r4r
r(oHcepBaHT
6enganK0HHt
xJropHA,
KOTOpbrr4
MOX(eT
a6cop6upoBarbct
KoHTaKTHrIMH
JIHH3aMH.
llepel
3ar(anbrBaHueM
npenapara
JrHH3br
cneAyer
cHrrb
u
ycraHoBHTb
odparHo
He paHee,
qeM r{epe3
15-2A
MHH
nocJre
H
HcTprJrrr.fl
uHr4
npeilap
aTa.
flpa
[pHMeH
eHHu
rtperrapara
HeJIb3.x
fipuKacarbcs
KoHr{HKoM
nHnerKH
K KaKofi-nu6o
roBepxHocru
so
Hs6exaHue
nora4anr4fr,
6axrep
uia nwyrpb
SnaroHa.
ffpweHeHue
6 neduampuu
Her
Ao